SCOPUS 정보 검색 플랫폼

JAMA

Volumn 284, Issue 23, 2000, Pages 3047-3049

Drug labeling revisions - Guaranteed to fail?

(1) Woosley, R L a

a GEORGETOWN UNIVERSITY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; CISAPRIDE; MIBEFRADIL;

DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; DRUG INFORMATION; DRUG LABELING; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; LAW; LIVER FAILURE; NOTE; PATIENT EDUCATION; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

EID: 0034694911 PISSN: 00987484 EISSN: None Source Type: Journal
DOI: 10.1001/jama.284.23.3047 Document Type: Note

Times cited : (39)

References (17)

1
- 0034694849
- Contraindicated use of cisapride: Impact of Food and Drug Administration regulatory action
- (2000) JAMA , vol.284 , pp. 3036-3039
- Smalley, W.¹ Shatin, D.² Wysowski, D.K.³

2
- 0006866008
- FDA talk paper: FDA updates warnings for cisapride

4
- 0006794125
- FDA talk paper: FDA proposes to withdraw Seldane approval

8
- 0003413171
- Washington, DC: Institute of Medicine
- (2000) To Err Is Human: Building a Safer Health System

9
- 0034328084
- How many deaths are due to medical errors?
- (2000) JAMA , vol.284 , pp. 2187-2188
- Honig, P.K.¹ Phillips, J.² Woodcock, J.³

10
- 0003984768
- Montvale, NJ: Medical Economics Co
- (2000) Physicians' Desk Reference. 54th ed. , pp. 1451-1452

11
- 0031015120
- Implementation of multiple outpatient formularies: Undesirable effects
- (1997) Clin Pharmacol Ther , vol.61 , pp. 1-7
- Stein, C.M.¹ Wood, A.J.J.² Pincus, T.³

12
- 0033591952
- Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
- (1999) JAMA , vol.282 , pp. 267-270
- Leape, L.L.¹ Cullen, D.J.² Clapp, M.D.³

13
- 0029968234
- Pharmacies and prevention of potentially fatal drug interactions
- (1996) JAMA , vol.275 , pp. 1086-1087
- Cavuto, N.J.¹ Woosley, R.L.² Sale, M.³

14
- 0003150022
- Radnor, Pa: Wyeth-Ayerst
- (1999) The Wyeth-Ayerst Prescription Drug Benefit Cost and Plan Design Survey Report, No. 28

15
- 0006759622
- Prescription drug product labeling: medication guide requirements, 21 CFR 44182-244252
- (1995)

16
- 0028272428
- Centers for education and research in therapeutics
- (1992) Clin Pharmacol Ther , vol.55 , pp. 249-255
- Woosley, R.L.¹

17
- 0033841677
- Centers for education and research in therapeutics
- (2000) Clin Pharmacol Ther , vol.68 , pp. 109-110
- Reidenberg, M.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.